Gypenosides Improve Diabetic Cardiomyopathy by Inhibiting ROS-mediated NLRP3 Inflammasome Activation
Journal of Cellular and Molecular Medicine - United Kingdom
doi 10.1111/jcmm.13743
Full Text
Open PDFAbstract
Available in full text
Date
July 11, 2018
Authors
Publisher
Wiley